Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cell Death & Disease|April 20, 2024
Zebrafish polg2 knock-out recapitulates human POLG-disorders; implications for drug treatmentRaquel Brañas Casas, Alessandro Zuppardo, Giovanni Risato, et al.
Redox Biology|May 27, 2025
Disulfide-mediated tetramerization of TRAP1 fosters its antioxidant and pro-neoplastic activitiesFiorella Faienza, Claudio Laquatra, Matteo Castelli, et al.
Oncotarget|April 13, 2016
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesisMarta Anna Kowalik, Giulia Guzzo, Andrea Morandi, et al.
Cell Stress & Chaperones|February 27, 2026
New Allosteric Modulators of Molecular Chaperone TRAP1 from the Integration of Computational Biology, Medicinal Chemistry, and BiophysicsFederica Guarra, Denis Komarov, Andrea Ciamarone, et al.
Cell Reports|January 19, 2017
Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1Ionica Masgras, Francesco Ciscato, Anna Maria Brunati, et al.
Communications Biology|November 11, 2024
N-terminal cleavage of cyclophilin D boosts its ability to bind F-ATP synthaseGabriele Coluccino, Alessandro Negro, Antonio Filippi, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 7, 2023
Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenograftsDaniele Boso, Martina Tognon, Matteo Curtarello, et al.
Cancer Research|November 9, 2014
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cellsMatteo Curtarello, Elisabetta Zulato, Giorgia Nardo, et al.
Journal of Hepatology|January 19, 2020
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogrammingMarta Anna Kowalik, Elisabetta Puliga, Lavinia Cabras, et al.
Pageof 8